Tech Center 1600 • Art Units: 1622 1625
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18019368 | HETEROGENEOUS CATALYZED PROCESS FOR THE PRODUCTION OF 2,2,4,6,6-PENTAMETHYL-1,2,5,6-TETRAHYDRO-PYRIMIDINE | Non-Final OA | BASF SE |
| 18253094 | ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | Non-Final OA | Vanderbilt University |
| 18023661 | INHIBITORS OF SARS COV-2 INFECTION AND USES THEREOF | Non-Final OA | The Board of Regents of the University of Texas System |
| 18032901 | TREATMENT OF EYE CONDITIONS | Non-Final OA | The University of Birmingham |
| 18029734 | HAIR CARE COMPOSITION | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18262233 | PROCESSES RELATED TO FORMATION OF N-(3-CHLORO-1-(PYRIDIN-3-YL)-1H-PYRAZOL-4-YL)-2-(METHYLSULFONYL)PROPANAMIDE | Non-Final OA | CORTEVA AGRISCIENCE LLC |
| 18158327 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINOPATHY AND OTHER OCULAR DISEASES | Final Rejection | Lankenau Institute for Medical Research |
| 18497338 | METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER | Final Rejection | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 18259888 | COMPOUNDS AND METHODS FOR MODULATING FXR | Non-Final OA | Terns Pharmaceuticals, Inc. |
| 18328009 | EXTRACTION OF CANNABINOIDS FROM WET BIOMASS | Non-Final OA | CHEMTOR, LP |
| 18327552 | TREATMENT OF NEUROLOGICAL DISORDERS | Non-Final OA | BioCorRx Pharmaceuticals Inc. |
| 18307992 | NOVEL COCRYSTALS OF DEXAMETHASONE | Non-Final OA | Advanced Biomedical Instrumentation Centre Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy